Top Markets
Coin of the day
Hexima Limited Hexima Limited

Hexima Limited

HXL
Rangering i aksjer #39776
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Aksjekurs
$0.0084929
Sist synkronisert: 2024-11-12
Markedsverdi
$354.66K
Endring (1 dag)
-0.64%
Endring (1 år)
0.00%
Land
AU
Handel Hexima Limited (HXL)

Kategori

P/B-forhold for Hexima Limited (HXL)
P/B-forhold per 2026 TTM: 0
Ifølge Hexima Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Hexima Limited fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE